Evidence map›Paper›PMID 31057740›Full record

ArticleMedChemComm2019

Preparation and evaluation of

Mohini Guleria, Tapas Das, Kusum Vats, Jeyachitra Amirdhanayagam, Anupam Mathur, Haladhar D Sarma, Ashutosh Dash

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedChemComm, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Novel Chlorin with a HYNIC: Synthesis,Molecules (Basel, Switzerland) · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohini GuleriaRadiopharmaceuticals Division , Bhabha Atomic Research Centre , Trombay , Mumbai - 400085 , India . Email: tdas@barc.gov.in ; ; Tel: +91 22 2559 0613.
Tapas DasRadiopharmaceuticals Division , Bhabha Atomic Research Centre , Trombay , Mumbai - 400085 , India . Email: tdas@barc.gov.in ; ; Tel: +91 22 2559 0613.ORCID 0000-0003-2877-0683
Kusum VatsRadiopharmaceuticals Division , Bhabha Atomic Research Centre , Trombay , Mumbai - 400085 , India . Email: tdas@barc.gov.in ; ; Tel: +91 22 2559 0613.
Jeyachitra AmirdhanayagamRadiopharmaceuticals Division , Bhabha Atomic Research Centre , Trombay , Mumbai - 400085 , India . Email: tdas@barc.gov.in ; ; Tel: +91 22 2559 0613.
Anupam MathurRadiopharmaceuticals Program , Board of Radiation and Isotope Technology , Vashi , Navi Mumbai - 400703 , India.
Haladhar D SarmaRadiation Biology and Health Sciences Division , Bhabha Atomic Research Centre , Trombay , Mumbai - 400085 , India.
Ashutosh DashRadiopharmaceuticals Division , Bhabha Atomic Research Centre , Trombay , Mumbai - 400085 , India . Email: tdas@barc.gov.in ; ; Tel: +91 22 2559 0613.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porphyrins are tetrapyrrolic macrocyclic ligands known for their affinity towards neoplastic tissues and once radiolabeled with a suitable diagnostic radioisotope could potentially be used for the imaging of tumorous lesions. In the present study, an unsymmetrically substituted porphyrin derivative namely 5-(

Identifiers

PMID31057740
PMCPMC6482877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.